Omnicare, Inc. (NYSE:OCR)

CAPS Rating: 4 out of 5

A geriatric pharmaceutical services company, which provides pharmaceuticals and related ancillary pharmacy services to long-term healthcare institutions. Operates in two business segments: Pharmacy Services and Contract Research Organization Services.

Results 21 - 34 of 34 : « Previous 1 2

Recs

0
Member Avatar cddg (< 20) Submitted: 1/24/2007 9:18:02 AM : Outperform Start Price: $37.70 OCR Score: -12.51

think guidence could come in better than the street expects on PDP rates and restructuring

Recs

0
Member Avatar PearlandTX (< 20) Submitted: 12/29/2006 12:59:15 PM : Outperform Start Price: $37.95 OCR Score: -13.76

Operates in a naturally strong sector -- geriatric pharmaceutical services. People are living longer and increasing their reliance pharma to maintain quality of life. Reasonably strong financial condition. Stock close to 52-week low. PEG less than 1.

Recs

0
Member Avatar fmurphyiii (43.50) Submitted: 12/28/2006 10:48:11 AM : Outperform Start Price: $38.07 OCR Score: -13.96

Undervalued because of rough stretch last year. Has everything in place to excel. Watch for possible negative regulatory environment and evidence of further customer retention issues.

Recs

0
Member Avatar kmortwein (< 20) Submitted: 12/8/2006 8:54:25 AM : Outperform Start Price: $39.93 OCR Score: -18.59

regulatory issues appear to be clearing
increasing services available

Recs

0
Member Avatar kea11 (75.43) Submitted: 12/7/2006 9:49:28 PM : Outperform Start Price: $39.93 OCR Score: -18.59

STrong position to negotiate best contracts

Recs

0
Member Avatar drkennyg (< 20) Submitted: 10/12/2006 7:41:09 PM : Outperform Start Price: $43.96 OCR Score: -29.61

will weather recent storm with ease

Recs

1
Member Avatar pkberneburg (86.07) Submitted: 10/10/2006 11:10:10 AM : Outperform Start Price: $42.30 OCR Score: -27.40

Recovery pick

Recs

5
Member Avatar Durwood1 (< 20) Submitted: 10/6/2006 10:51:25 AM : Outperform Start Price: $42.89 OCR Score: -29.05

Great Company - market leader in the institutional pharmacy arena. Customers are a captive audience and the aging population is sure to keep filling beds. Recent hiccups due to regulatory issues will pass. Reimbursements with Medicare may be a long-term issue, but Medicare will never allow these companies to fail.

Recs

3
Member Avatar soweto624 (< 20) Submitted: 10/4/2006 1:49:43 AM : Outperform Start Price: $41.17 OCR Score: -27.08

I believe it has the ability to generate strong free cash flow as its earnings grow both organically and through acquisitions. Transition to Medicare D has been a disaster, which pushed the stock down excessively.

Recs

0
Member Avatar cockeagledrvr (80.16) Submitted: 10/2/2006 12:15:23 AM : Outperform Start Price: $41.69 OCR Score: -27.43

The U.S. isn't getting any younger and with the price of drugs someone has got to be making money. Why not Omnicare?

Recs

0
Member Avatar eddiet0729 (72.33) Submitted: 9/27/2006 6:00:58 PM : Outperform Start Price: $41.75 OCR Score: -27.67

Fair value price of 45.00.

Recs

1
Member Avatar kevinbshaw (< 20) Submitted: 9/15/2006 2:26:38 PM : Underperform Start Price: $43.06 OCR Score: +30.95

Roll up story is done. Core operating ability is weak.

Recs

2
Member Avatar redbus109 (< 20) Submitted: 8/27/2006 4:46:55 AM : Outperform Start Price: $41.96 OCR Score: -31.72

OCR has a domionant position in the supply of pahrmaceuticals to nursing homes. Presently they are being investigated for fraud, but over the long term, demographics will yield superior sales and income growth

Recs

2
Member Avatar deckdawg (52.42) Submitted: 5/26/2006 6:57:10 PM : Outperform Start Price: $44.86 OCR Score: -38.09

This pharmcacy distributor specializes in nursing homes. Recommended by IV and then sold by IV for close to 100% gain. Has now dropped into mildy undervalued range. Expect 20% appreciation over next year.

Results 21 - 34 of 34 : « Previous 1 2

Featured Broker Partners


Advertisement